14-Aug-2018 | Zion Market Research
Zion Market Research has published a new report titled “Cartilage Repair/Regeneration Market by Treatment Modality (Cell-Based and Non-Cell Based), by Treatment (Cartilage Replacement and Cartilage Repair), by Type (Fibro Cartilage, Hyaline Cartilage, and Elastic Cartilage), and by End-Use (Ambulatory Surgical Centers, Hospitals & Clinics, Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis & Forecast, 2017 - 2024”. According to the report, global cartilage repair/regeneration market was valued at approximately USD 4.3 billion in 2017 and is expected to generate revenue of around USD 6.5 billion by end of 2024, growing at a CAGR of around 5.8% between 2018 and 2024.
The primary factor driving the global cartilage repair/regeneration market is the growing prevalence of joints & bones disorders all across the globe. Increasing obese and geriatric population base all across the globe are the prominent factors driving the cartilage repair/regeneration market. According to the World Health Organization, by 2050 the number of people of age 60 or above will get doubled and is estimated to reach a value of 2.1 billion globally, from 962 million in 2017 globally.
Browse the full "Cartilage Repair/Regeneration Market by Treatment Modality (Cell-Based and Non-Cell Based), by Treatment (Cartilage Replacement and Cartilage Repair), by Type (Fibro Cartilage, Hyaline Cartilage, and Elastic Cartilage), and by End-Use (Ambulatory Surgical Centers, Hospitals & Clinics, Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis & Forecast, 2017 - 2024 " report at https://www.zionmarketresearch.com/report/cartilage-repair-cartilage-regeneration-market
According to the NIH (National Institute of Health), one-third of the adults in America aged above 45, generally suffer from cartilage damage issue. However, the high cost of treatment is acting as a hurdle for the cartilage repair/regeneration market and may affect its growth in the long term. Nonetheless, a significant investment by the government for the development of the process & therapies used for the treatment of cartilage damage along with the growing awareness are likely to disclose the new avenues for the market.
The cartilage repair/regeneration market is divided by treatment modality, type, treatment, and end-use.
Based on treatment modality, the cartilage repair/regeneration market has been segmented into cell-based and non-cell based. The cell-based segment is sub-segmented into growth factor technology, chondrocyte transplantation, and stem cells and the non-cell based segment is sub-segmented into cell-free composites, tissue scaffolds, and stem cells. By treatment modality, the cell-based treatment is estimated to hold the largest market value share attributed to the fact of long-term & effective results.
On the basis of treatment, cartilage repair/regeneration market has been segmented into cartilage replacement and cartilage repair. The cartilage replacement segment is sub-segmented into autologous chondrocyte implantation and osteochondral transplant and the cartilage repair segment is sub-segmented into cell-based cartilage resurfacing, microfracture, and non-surgical treatment.
By type segment, the cartilage repair/regeneration market is categorized into fibrocartilage, hyaline cartilage, and elastic cartilage.
Based on end use, the cartilage repair/regeneration market is classified into ambulatory surgical centers, surgical centers, hospital & clinics, and others. Hospital & clinics segment holds the maximum share and is expected to boost the market over the forecast period
Based on region, the global cartilage repair/regeneration market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In the cartilage repair/regeneration market, North America is anticipated to dominate the regional segment. Furthermore, in the North America region, the U.S. is estimated to witness significant demand for cartilage repair/regeneration therapies. Europe is estimated to be following the footsteps of North America. Asia Pacific region is expected to be the significantly growing region for cartilage repair/regeneration market in the near future. Additionally, Latin America and the Middle East & Africa will show moderate CAGR in cartilage repair/regeneration market.
Some of the key players in cartilage repair/regeneration market include Osiris Therapeutics, Inc., Smith & Nephew Plc, Vericel Corporation, Depuy Synthes, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Anika Therapeutics S. R. L, Conmed Linvatec, RTI Surgical, Arthrex, Inc., etc.
This report segments the global cartilage repair/regeneration market as follows:
Global Cartilage Repair/Regeneration Market: By Treatment Modality
Global Cartilage Repair/Regeneration Market: By Type
Global Cartilage Repair/Regeneration Market: By Treatment
Global Cartilage Repair/Regeneration Market: By End-Use
Global Cartilage Repair/Regeneration Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651